<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03668782</url>
  </required_header>
  <id_info>
    <org_study_id>24/2018 Fondazione Leonardo</org_study_id>
    <nct_id>NCT03668782</nct_id>
  </id_info>
  <brief_title>Cord Milking in Elective Cesarean Section</brief_title>
  <official_title>Efficacy of Umbilical Cord Milking in Elective Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Policlinico Abano Terme</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Policlinico Abano Terme</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study was to investigate the efficacy and safety of umbilical cord
      milking as compared with immediate cord clamping on placental transfusion, estimated by Δ
      hematocrit between cord blood at birth and capillary heel hematocrit at 48 hours of age, in
      elective cesarean delivered neonates.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2018</start_date>
  <completion_date type="Anticipated">February 28, 2019</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Placental transfusion</measure>
    <time_frame>48 hours</time_frame>
    <description>Δ hematocrit between cord blood at birth and capillary heel hematocrit at 48 hours of age</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Placental Transfusion</condition>
  <arm_group>
    <arm_group_label>immediate cord clamping</arm_group_label>
    <description>Tthe umbilical cord of neonates was cut and clamped.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>umbilical cord milking.</arm_group_label>
    <description>Tthe umbilical cord of neonates was milked.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Umbilical cord milking</intervention_name>
    <description>The babies were held at the level of the placenta, while the umbilical cord was milked or cut and clamped.</description>
    <arm_group_label>immediate cord clamping</arm_group_label>
    <arm_group_label>umbilical cord milking.</arm_group_label>
    <other_name>Immediate cord clamping</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      After the infant was delivered, the obstetrician either immediately clamped and cut the cord
      or initiated the milking protocol intervention, near the cord insertion site on the placenta
      towards the infant, three times before clamping.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All women who presented for an elective cesarean section were screened for eligibility.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: singleton low risk pregnancy, gestational age of 39 to 40/0 weeks
        confirmed by a first trimester ultrasound, no evidence of active labor, 18 years of age,
        and (5) a written consent given by the woman.

        -

        Exclusion Criteria:maternal medical and obstetric complications, severe anemia, clotting
        disorders and suspected intrauterine growth restriction

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Policlinico Abano Terme</name>
      <address>
        <city>Abano Terme</city>
        <country>Italy</country>
      </address>
    </facility>
    <contact>
      <last_name>Vincenzo Zanardo, ND</last_name>
      <phone>049720027</phone>
      <phone_ext>+39</phone_ext>
      <email>viincenzo.zanardo@libero.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>September 11, 2018</study_first_submitted>
  <study_first_submitted_qc>September 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2018</study_first_posted>
  <last_update_submitted>September 11, 2018</last_update_submitted>
  <last_update_submitted_qc>September 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Policlinico Abano Terme</investigator_affiliation>
    <investigator_full_name>Vincenzo Zanardo</investigator_full_name>
    <investigator_title>Director of Perinatal Medicine</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

